Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation.

Myeloablative conditioning before bone marrow transplantation (BMT) results in thymic epithelial cell (TEC) injury, T-cell immune deficiency, and susceptibility to opportunistic infections. Conditioning regimen-induced TEC damage directly contributes to slow thymopoietic recovery after BMT. Keratino...

Full description

Bibliographic Details
Main Authors: Kelly, R, Goren, E, Taylor, P, Mueller, SN, Stefanski, H, Osborn, M, Scott, H, Komarova, E, Gudkov, A, Holländer, G, Blazar, B
Format: Journal article
Language:English
Published: 2010
_version_ 1797099541718106112
author Kelly, R
Goren, E
Taylor, P
Mueller, SN
Stefanski, H
Osborn, M
Scott, H
Komarova, E
Gudkov, A
Holländer, G
Blazar, B
author_facet Kelly, R
Goren, E
Taylor, P
Mueller, SN
Stefanski, H
Osborn, M
Scott, H
Komarova, E
Gudkov, A
Holländer, G
Blazar, B
author_sort Kelly, R
collection OXFORD
description Myeloablative conditioning before bone marrow transplantation (BMT) results in thymic epithelial cell (TEC) injury, T-cell immune deficiency, and susceptibility to opportunistic infections. Conditioning regimen-induced TEC damage directly contributes to slow thymopoietic recovery after BMT. Keratinocyte growth factor (KGF) is a TEC mitogen that stimulates proliferation and, when given before conditioning, reduces TEC injury. Some TEC subsets are refractory to KGF and functional T-cell responses are not fully restored in KGF-treated BM transplant recipients. Therefore, we investigated whether the addition of a pharmacologic inhibitor, PFT-beta, to transiently inhibit p53 during radiotherapy could spare TECs from radiation-induced damage in congenic and allogeneic BMTs. Combined before BMT KGF + PFT-beta administration additively restored numbers of cortical and medullary TECs and improved thymic function after BMT, resulting in higher numbers of donor-derived, naive peripheral CD4(+) and CD8(+) T cells. Radiation conditioning caused a loss of T-cell zone fibroblastic reticular cells (FRCs) and CCL21 expression in lymphoid stroma. KGF + PFT-beta treatment restored both FRC and CCL21 expression, findings that correlated with improved T-cell reconstitution and an enhanced immune response against Listeria monocytogenes infection. Thus, transient p53 inhibition combined with KGF represents a novel and potentially translatable approach to promote rapid and durable thymic and peripheral T-cell recovery after BMT.
first_indexed 2024-03-07T05:25:14Z
format Journal article
id oxford-uuid:e050843f-733a-4028-9ccb-977802b5ebe7
institution University of Oxford
language English
last_indexed 2024-03-07T05:25:14Z
publishDate 2010
record_format dspace
spelling oxford-uuid:e050843f-733a-4028-9ccb-977802b5ebe72022-03-27T09:46:22ZShort-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e050843f-733a-4028-9ccb-977802b5ebe7EnglishSymplectic Elements at Oxford2010Kelly, RGoren, ETaylor, PMueller, SNStefanski, HOsborn, MScott, HKomarova, EGudkov, AHolländer, GBlazar, BMyeloablative conditioning before bone marrow transplantation (BMT) results in thymic epithelial cell (TEC) injury, T-cell immune deficiency, and susceptibility to opportunistic infections. Conditioning regimen-induced TEC damage directly contributes to slow thymopoietic recovery after BMT. Keratinocyte growth factor (KGF) is a TEC mitogen that stimulates proliferation and, when given before conditioning, reduces TEC injury. Some TEC subsets are refractory to KGF and functional T-cell responses are not fully restored in KGF-treated BM transplant recipients. Therefore, we investigated whether the addition of a pharmacologic inhibitor, PFT-beta, to transiently inhibit p53 during radiotherapy could spare TECs from radiation-induced damage in congenic and allogeneic BMTs. Combined before BMT KGF + PFT-beta administration additively restored numbers of cortical and medullary TECs and improved thymic function after BMT, resulting in higher numbers of donor-derived, naive peripheral CD4(+) and CD8(+) T cells. Radiation conditioning caused a loss of T-cell zone fibroblastic reticular cells (FRCs) and CCL21 expression in lymphoid stroma. KGF + PFT-beta treatment restored both FRC and CCL21 expression, findings that correlated with improved T-cell reconstitution and an enhanced immune response against Listeria monocytogenes infection. Thus, transient p53 inhibition combined with KGF represents a novel and potentially translatable approach to promote rapid and durable thymic and peripheral T-cell recovery after BMT.
spellingShingle Kelly, R
Goren, E
Taylor, P
Mueller, SN
Stefanski, H
Osborn, M
Scott, H
Komarova, E
Gudkov, A
Holländer, G
Blazar, B
Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation.
title Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation.
title_full Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation.
title_fullStr Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation.
title_full_unstemmed Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation.
title_short Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation.
title_sort short term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances t cell reconstitution after murine bone marrow transplantation
work_keys_str_mv AT kellyr shortterminhibitionofp53combinedwithkeratinocytegrowthfactorimprovesthymicepithelialcellrecoveryandenhancestcellreconstitutionaftermurinebonemarrowtransplantation
AT gorene shortterminhibitionofp53combinedwithkeratinocytegrowthfactorimprovesthymicepithelialcellrecoveryandenhancestcellreconstitutionaftermurinebonemarrowtransplantation
AT taylorp shortterminhibitionofp53combinedwithkeratinocytegrowthfactorimprovesthymicepithelialcellrecoveryandenhancestcellreconstitutionaftermurinebonemarrowtransplantation
AT muellersn shortterminhibitionofp53combinedwithkeratinocytegrowthfactorimprovesthymicepithelialcellrecoveryandenhancestcellreconstitutionaftermurinebonemarrowtransplantation
AT stefanskih shortterminhibitionofp53combinedwithkeratinocytegrowthfactorimprovesthymicepithelialcellrecoveryandenhancestcellreconstitutionaftermurinebonemarrowtransplantation
AT osbornm shortterminhibitionofp53combinedwithkeratinocytegrowthfactorimprovesthymicepithelialcellrecoveryandenhancestcellreconstitutionaftermurinebonemarrowtransplantation
AT scotth shortterminhibitionofp53combinedwithkeratinocytegrowthfactorimprovesthymicepithelialcellrecoveryandenhancestcellreconstitutionaftermurinebonemarrowtransplantation
AT komarovae shortterminhibitionofp53combinedwithkeratinocytegrowthfactorimprovesthymicepithelialcellrecoveryandenhancestcellreconstitutionaftermurinebonemarrowtransplantation
AT gudkova shortterminhibitionofp53combinedwithkeratinocytegrowthfactorimprovesthymicepithelialcellrecoveryandenhancestcellreconstitutionaftermurinebonemarrowtransplantation
AT hollanderg shortterminhibitionofp53combinedwithkeratinocytegrowthfactorimprovesthymicepithelialcellrecoveryandenhancestcellreconstitutionaftermurinebonemarrowtransplantation
AT blazarb shortterminhibitionofp53combinedwithkeratinocytegrowthfactorimprovesthymicepithelialcellrecoveryandenhancestcellreconstitutionaftermurinebonemarrowtransplantation